Evropská unie -
čeština -
EMA (European Medicines Agency)
ozawade
bioprojet pharma - pitlisant - sleep apnea, obstructive - další léky na nervový systém - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).
Evropská unie -
čeština -
EMA (European Medicines Agency)
wakix
bioprojet pharma - pitlisant - narkolepsie - další léky na nervový systém - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.
Evropská unie -
čeština -
EMA (European Medicines Agency)
ghryvelin (previously macimorelin aeterna zentaris)
atnahs pharma netherlands b.v. - macimorelin acetát - diagnostické techniky, endokrinní - macimorelin - tento léčivý přípravek je určen pouze pro diagnostické účely. ghryvelin is indicated for the diagnosis of growth hormone deficiency (ghd) in adults.